Market Research Logo

Europe Melanoma Epidemiology and Patient Flow Analysis - 2017

Europe Melanoma Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Melanoma patients study in a new report ‘Europe Melanoma Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Melanoma epidemiology, Melanoma diagnosed patients, and Melanoma treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Melanoma derived from epidemiological analysis, percentage of patients diagnosed with Melanoma, and percentage of patients treated with a therapy.

The study helps executives estimate Melanoma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Melanoma prevalence, Melanoma diagnosis rate, and Melanoma treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Melanoma Patient Flow
  • Melanoma Prevalence
  • Melanoma Diagnosed Patients
  • Melanoma Treated Patients


1. Melanoma: Disease Definition
2. Melanoma Patient Flow in Europe
2A. Melanoma Prevalence in Europe
2B. Melanoma Diagnosed Patients in Europe
2C. Melanoma Treated Patients in Europe
3. Melanoma Patient Flow in Germany
3A. Melanoma Prevalence in Germany
3B. Melanoma Diagnosed Patients in Germany
3C. Melanoma Treated Patients in Germany
4. Melanoma Patient Flow in France
4A. Melanoma Prevalence in France
4B. Melanoma Diagnosed Patients in France
4C. Melanoma Treated Patients in France
5. Melanoma Patient Flow in Spain
5A. Melanoma Prevalence in Spain
5B. Melanoma Diagnosed Patients in Spain
5C. Melanoma Treated Patients in Spain
6. Melanoma Patient Flow in Italy
6A. Melanoma Prevalence in Italy
6B. Melanoma Diagnosed Patients in Italy
6C. Melanoma Treated Patients in Italy
7. Melanoma Patient Flow in UK
7A. Melanoma Prevalence in UK
7B. Melanoma Diagnosed Patients in UK
7C. Melanoma Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Melanoma Patient Flow in Europe, 2016
Table 2: Melanoma Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Melanoma Patient Flow in Germany, 2016
Table 4: Melanoma Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Melanoma Patient Flow in France, 2016
Table 6: Melanoma Patient Flow Forecast in France, 2016 - 2025
Table 7: Melanoma Patient Flow in Spain, 2016
Table 8: Melanoma Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Melanoma Patient Flow in Italy, 2016
Table 10: Melanoma Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Melanoma Patient Flow in UK, 2016
Table 12: Melanoma Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Melanoma Patient Flow in Europe, 2016
Figure 2: Melanoma Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Melanoma Patient Flow in Germany, 2016
Figure 4: Melanoma Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Melanoma Patient Flow in France, 2016
Figure 6: Melanoma Patient Flow Forecast in France, 2016 - 2025
Figure 7: Melanoma Patient Flow in Spain, 2016
Figure 8: Melanoma Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Melanoma Patient Flow in Italy, 2016
Figure 10: Melanoma Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Melanoma Patient Flow in UK, 2016
Figure 12: Melanoma Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report